Home » Topics » Conferences

Conferences
RSS

TX-525, a potent synthetic progestin with low androgenic potential

June 30, 1998

Oxidized phenolic compounds with an unexpected mechanism of action

June 30, 1998

Various schedules and doses of DMDC explored in phase I

June 29, 1998

Pyrazoloacridine evaluated in patients with pancreatic and hepatobiliary cancer

June 29, 1998

Preclinical studies with doranidazole summarized

June 29, 1998

New class of FPTase inhibitors discovered at Merck & Co.

June 29, 1998

Melphalan derivative pinpointed for further study

June 29, 1998

rAd-p53 in gene therapy of cancers with p53 mutation; overview of gene therapies in development

June 29, 1998

Potential use of BSH in boron neutron capture therapy evaluated in clinical trials

June 26, 1998

U.K. investigators identify interesting candidate for clinical evaluation

June 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...